15026509758
当前位置：上海谷博实业有限公司>>科研试剂>>美国cayman>> Cayman-10011255-10NSC 210902
| NSC 210902 | Cayman-10011255-10 |
| NSC 210902 | Cayman-10011255-5 |
| Cayman-10011255-50 | |
| CAY10577 | Cayman-10011256-1 |
| CAY10577 | Cayman-10011256-10 |
| CAY10577 | Cayman-10011256-5 |
| CAY10577 | Cayman-10011256-50 |
| Transcription Factor NF-κB （p50） Combo Positive Control | Cayman-10011257-1 |
| Transcription Factor NF-κB （p50） Combo Primary Antibody | Cayman-10011258-1 |
| Transcription Factor NF-κB （p65） Combo Primary Antibody | Cayman-10011259-1 |
| 15-Lipoxygenase-2 （human recombinant） | Cayman-10011263-100 |
| 15-Lipoxygenase-2 （human recombinant） | Cayman-10011263-25 |
| 15-Lipoxygenase-2 （human recombinant） | Cayman-10011263-50 |
| CAY10578 | Cayman-10011264-1 |
| CAY10578 | Cayman-10011264-10 |
| CAY10578 | Cayman-10011264-25 |
| CAY10578 | Cayman-10011264-5 |
| Fulvestrant | Cayman-10011269-1 |
| Fulvestrant | Cayman-10011269-10 |
| Fulvestrant | Cayman-10011269-5 |
| Fulvestrant | Cayman-10011269-50 |
| γ-CEHC AChE Tracer | Cayman-10011273-100 |
| γ-CEHC AChE Tracer | Cayman-10011273-500 |
| γ-CEHC EIA Antiserum | Cayman-10011274-100 |
| γ-CEHC EIA Antiserum | Cayman-10011274-500 |
| γ-CEHC EIA Standard | Cayman-10011275-1 |
| Chenodeoxycholic Acid | Cayman-10011286-1 |
| Chenodeoxycholic Acid | Cayman-10011286-10 |
| Chenodeoxycholic Acid | Cayman-10011286-25 |
| Chenodeoxycholic Acid | Cayman-10011286-5 |
| Half Volume 96-Well Plate （White） | Cayman-10011288-1 |
| Half Volume 96-Well Plate （White） | Cayman-10011288-5 |
| （E）-Guggulsterone | Cayman-10011296-10 |
| （E）-Guggulsterone | Cayman-10011296-25 |
| （E）-Guggulsterone | Cayman-10011296-5 |
| （E）-Guggulsterone | Cayman-10011296-50 |
| 96-Well Black Plate with lid | Cayman-10011297-1 |
| 96-Well Black Plate with lid | Cayman-10011297-5 |
| Stearic Acid | Cayman-10011298-1000 |
| Stearic Acid | Cayman-10011298-10000 |
| Stearic Acid | Cayman-10011298-500 |
| Stearic Acid | Cayman-10011298-5000 |
| NBD-Stearoyl-2-Arachidonoyl-sn-glycerol | Cayman-10011300-1 |
| NBD-Stearoyl-2-Arachidonoyl-sn-glycerol | Cayman-10011300-10 |
| NBD-Stearoyl-2-Arachidonoyl-sn-glycerol | Cayman-10011300-5 |
| NBD-Stearoyl-2-Arachidonoyl-sn-glycerol | Cayman-10011300-500 |
| p38 MAPK Monoclonal Antibody （Clone 9F12） | Cayman-10011301-1 |
| 17（S）-HETE | Cayman-10011305-100 |
| 17（S）-HETE | Cayman-10011305-25 |
| 17（S）-HETE | Cayman-10011305-50 |
| 17（S）-HETE | Cayman-10011305-500 |
| Goat Anti-Rabbit HRP Conjugate | Cayman-10011320-1 |
| Goat Anti-Rabbit HRP Conjugate | Cayman-10011320-5 |
| 8-iso Prostaglandin E2-d4 | Cayman-10011321-100 |
| 8-iso Prostaglandin E2-d4 | Cayman-10011321-25 |
| 8-iso Prostaglandin E2-d4 | Cayman-10011321-50 |
| 8-iso Prostaglandin E2-d4 | Cayman-10011321-500 |
| Cysteinyl Leukotriene Express EIA Monoclonal Antibody | Cayman-10011322-100 |
| Cysteinyl Leukotriene Express EIA Monoclonal Antibody | Cayman-10011322-500 |
| Cysteinyl Leukotriene Express AChE Tracer | Cayman-10011323-100 |
| Cysteinyl Leukotriene Express AChE Tracer | Cayman-10011323-500 |
| Immunoassay Buffer A Concentrate （10X） | Cayman-10011325-10 |
| Plerixafor （hydrochloride hydrate） | Cayman-10011332-1 |
| Plerixafor （hydrochloride hydrate） | Cayman-10011332-10 |
| Plerixafor （hydrochloride hydrate） | Cayman-10011332-5 |
| Plerixafor （hydrochloride hydrate） | Cayman-10011332-50 |
| Avenanthramide-C methyl ester | Cayman-10011336-1 |
| Avenanthramide-C methyl ester | Cayman-10011336-10 |
| Avenanthramide-C methyl ester | Cayman-10011336-5 |
| Avenanthramide-C methyl ester | Cayman-10011336-500 |
| Diphenylphosphine Acid | Cayman-10011337-10 |
| Diphenylphosphine Acid | Cayman-10011337-100 |
| Diphenylphosphine Acid | Cayman-10011337-5 |
| Diphenylphosphine Acid | Cayman-10011337-50 |
| Transcription Factor LXR 96-Well Plate | Cayman-10011338-96 |
| Transcription Factor LXR Specific Competitor dsDNA | Cayman-10011339-1 |
| Transcription Factor LXRβ Primary Antibody | Cayman-10011340-1 |
| LXRβ Transcription Factor Positive Control | Cayman-10011341-1 |
| Transcription Factor Mouse Anti-Goat HRP Conjugate | Cayman-10011342-1 |
| Rosiglitazone-d5 Maleate | Cayman-10011343-1 |
| Rosiglitazone-d5 Maleate | Cayman-10011343-10 |
| Rosiglitazone-d5 Maleate | Cayman-10011343-5 |
| Glycerophospho-N-Arachidonoyl Ethanolamine | Cayman-10011347-1 |
| Glycerophospho-N-Arachidonoyl Ethanolamine | Cayman-10011347-5 |
| Glycerophospho-N-Arachidonoyl Ethanolamine | Cayman-10011347-50 |
| Taprostene （sodium salt） | Cayman-10011348-1 |
| Taprostene （sodium salt） | Cayman-10011348-10 |
| Taprostene （sodium salt） | Cayman-10011348-5 |
| Taprostene （sodium salt） | Cayman-10011348-500 |
| Dimebolin （hydrochloride） | Cayman-10011349-1 |
| Dimebolin （hydrochloride） | Cayman-10011349-10 |
| Dimebolin （hydrochloride） | Cayman-10011349-100 |
| Dimebolin （hydrochloride） | Cayman-10011349-5 |
| Protocatechuate Dioxygenase | Cayman-10011353-1 |
| Protocatechuate Dioxygenase | Cayman-10011353-250 |
| Protocatechuate Dioxygenase | Cayman-10011353-500 |
| HRP Stop Solution | Cayman-10011355-12 |
| HRP Stop Solution | Cayman-10011355-30 |
| HRP Stop Solution | Cayman-10011355-60 |
| Glycerophospho-N-Palmitoyl Ethanolamine | Cayman-10011356-1 |
请输入账号
请输入密码
请输验证码
以上信息由企业自行提供，信息内容的真实性、准确性和合法性由相关企业负责，环保在线对此不承担任何保证责任。
温馨提示：为规避购买风险，建议您在购买产品前务必确认供应商资质及产品质量。
环保在线